Aclaris therapeutics to participate in two june healthcare investor conferences

Wayne, pa., june 02, 2023 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the aclaris management team will participate in two healthcare investor conferences in june.

ACRS Ratings Summary

ACRS Quant Ranking